CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Endothelin-1 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00745693
NCT00745693N/ACompleted

The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin

University of Edinburgh·interventional·Posted Sep 3, 2008·Updated May 17, 2024

In Brief

A clinical study evaluating Endothelin-1 and BQ-123 and BQ-788 for Coronary Disease. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this study is to identify the role of endothelin 1 (a natural vasoconstrictor) in the adverse vascular effects demonstrated after exposure to air pollution

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSweden
CollaboratorsUmeå University

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 3, 2008
Enrollment StartMar 1, 2008
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.8 years ago

Interventions

Endothelin-1drug

Intra-arterial infusion of Endothelin-1 at 5pmol/min for 1 hour during venous occlusion plethysmography

BQ-123 and BQ-788drug

1 hour intra-arterial infusion of BQ-123 at 10nmol/min followed by co-infusion of BQ-788 at 1nmol/min for a further hour during forearm venous occlusion plethysmography